Emit II Plus Oxycodone Assay
Enabling early detection of pain prescription abuse
The Emit II Plus Oxycodone assay offers 100 ng/mL and 300 ng/mL cutoffs and no cross-reactivity to structurally related compounds such as buprenorphine and hydrocodone.
- Achieve high specificity for oxycodone and oxymorphone to provide confidence for accurate results while meeting the SAMHSA requirements for oxycodone screening
- Reduce false results with an assay that has 98% agreement to LC-MS/MS for positive samples and 100% agreement for negatives.1
- Consolidate opioid testing with other Siemens Healthineers assays, enabling providers to screen patients on one trusted system
1. When using the 300 ng/mL cutoff. Data from the Emit II Plus Oxycodone Assay IFU